{"name":"INVITECH LTD","company_number":"06629960","status":"Active","type":"Private Limited Company","incorporated":"2008-06-25","dissolved":null,"registered_office":"Unit 5a - Calibre Scientific House Selden Way, Catcliffe, Rotherham, England, S60 5XA","postcode":"S60 5XA","sic_codes":[{"code":46460,"description":"Wholesale of pharmaceutical goods"}],"principal_activity":null,"previous_names":[],"warnings":[],"accounts":{"category":"Audit Exemption Subsidiary","year_end":"31 December","last_made_up_to":"2024-12-31","next_due":"2026-12-31"},"employees":{"count":3,"accounts_date":"2023-12-31"},"financials":[{"financial_date":"2023-12-31","net_assets":316504,"cash":263692,"average_employees":3},{"financial_date":"2022-12-31","net_assets":377691,"cash":384771,"average_employees":3},{"financial_date":"2021-12-31","net_assets":280005,"cash":412940},{"financial_date":"2020-12-31","net_assets":188542,"cash":194230},{"financial_date":"2019-12-31","net_assets":241068,"cash":259090}],"officers":{"current":3,"resigned":6,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":0,"outstanding":0},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"INVITECH LTD is a small, niche pharmaceutical wholesaler operating as a subsidiary of Molecular Dimensions Ltd, positioned in the specialist life sciences reagent segment rather than mainstream pharmaceutical distribution. While the company maintains strong liquidity (current ratio of 2.23:1) and benefits from parent company support, the 2023 financial performance is concerning – with an implied loss of approximately £61k, declining net assets, and a 66% increase in trade creditors suggesting working capital strain. The business operates with a lean 3-employee model that limits overhead but also constrains scalability, and its niche positioning insulates it from direct competition with major wholesalers whilst exposing it to specialist competitors with superior infrastructure. The strategic shift evidenced by significant capital expenditure on vehicles and inventory build suggests preparation for operational change, though the concurrent profitability decline raises questions about execution effectiveness.","website":"http://www.invitech.co.uk","links":{"page":"https://www.companiesintheuk.co.uk/ltd/invitech","people":"https://www.companiesintheuk.co.uk/company/invitech/people","filing_history":"https://www.companiesintheuk.co.uk/company/invitech/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/06629960","financials":"https://www.companiesintheuk.co.uk/company/invitech/financial","control":"https://www.companiesintheuk.co.uk/company/invitech/control","charges":"https://www.companiesintheuk.co.uk/company/invitech/charges","ai_analysis":"https://www.companiesintheuk.co.uk/company/invitech/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/invitech"}